Suvretta Capital Management 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 95 US equity positions worth $2.7bn in its Q2 2025 13F filing. The largest position was ARQT at 6.1% of the reported book, followed by 89BIO INC and LEGN. Against the Q1 2025 filing, it opened 5 new positions, added to 27 and reduced 12 among the top 50 holdings.
What did Suvretta Capital Management own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 6.1% | $161.7m | 11,535,582 | 1% | added |
| 2 | 89BIO INC | 5.3% | $139.5m | 14,210,000 | -1% | reduced | |
| 3 | LEGN LEGEND BIOTECH CORP | Healthcare | 5.0% | $133.9m | 3,774,009 | 1% | added |
| 4 | META META PLATFORMS INC | Communication Services | 4.7% | $125.4m | 169,845 | -5% | reduced |
| 5 | BENITEC BIOPHARMA INC | 4.4% | $115.6m | 9,876,506 | 0% | held | |
| 6 | KO COCA COLA CO | Consumer Defensive | 3.3% | $87.3m | 1,233,230 | 197% | added |
| 7 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.1% | $82.8m | 2,278,000 | 13% | added |
| 8 | GE GE AEROSPACE | Industrials | 3.0% | $79.9m | 310,262 | 55% | added |
| 9 | BHVN BIOHAVEN LTD | Healthcare | 3.0% | $79.3m | 5,620,271 | 0% | held |
| 10 | NVDA NVIDIA CORPORATION | Technology | 3.0% | $78.9m | 499,562 | 42% | added |
| 11 | AVBP ARRIVENT BIOPHARMA INC | 2.8% | $74.3m | 3,412,788 | 46% | added | |
| 12 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.6% | $68.0m | 300,401 | -14% | reduced |
| 13 | IMTX IMMATICS N.V | Healthcare | 2.4% | $64.7m | 12,030,129 | 32% | added |
| 14 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 2.4% | $64.0m | 6,804,091 | 0% | held |
| 15 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.3% | $60.8m | 428,460 | 8% | added |
| 16 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.1% | $56.6m | 398,799 | -1% | reduced |
| 17 | AMZN AMAZON COM INC | Consumer Cyclical | 2.1% | $56.5m | 257,625 | -27% | reduced |
| 18 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.1% | $56.0m | 4,955,000 | 1% | added | |
| 19 | DKS DICKS SPORTING GOODS INC | Consumer Cyclical | 1.9% | $51.5m | 260,465 | – | new |
| 20 | ORCL ORACLE CORP | Technology | 1.9% | $50.4m | 230,728 | 2% | added |
| 21 | APELLIS PHARMACEUTICALS INC | 1.9% | $49.8m | 2,878,000 | 75% | added | |
| 22 | MSFT MICROSOFT CORP | Technology | 1.9% | $49.2m | 98,828 | -45% | reduced |
| 23 | HD HOME DEPOT INC | Consumer Cyclical | 1.8% | $47.9m | 130,721 | 34% | added |
| 24 | KURA KURA ONCOLOGY INC | Healthcare | 1.8% | $46.8m | 8,116,000 | 9% | added |
| 25 | BAC BANK AMERICA CORP | Financial Services | 1.7% | $43.9m | 927,190 | 23% | added |
| 26 | COF CAPITAL ONE FINL CORP | Financial Services | 1.6% | $41.3m | 194,160 | -21% | reduced |
| 27 | FERG FERGUSON ENTERPRISES INC | Industrials | 1.6% | $41.3m | 189,660 | 46% | added |
| 28 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.5% | $39.4m | 532,280 | – | new |
| 29 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.4% | $38.0m | 353,561 | 35% | added |
| 30 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.3% | $35.0m | 5,082,900 | 0% | held |
| 31 | DHR DANAHER CORPORATION | Healthcare | 1.3% | $34.5m | 174,700 | 1185% | added |
| 32 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.1% | $30.0m | 3,688,858 | 44% | added |
| 33 | TSLA TESLA INC | Consumer Cyclical | 1.1% | $29.3m | 92,357 | -24% | reduced |
| 34 | AURA AURA BIOSCIENCES INC | 1.0% | $27.4m | 4,372,884 | 60% | added | |
| 35 | INSM INSMED INC | Healthcare | 0.9% | $24.0m | 238,783 | -84% | reduced |
| 36 | DDOG DATADOG INC | Technology | 0.9% | $24.0m | 178,832 | -2% | reduced |
| 37 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.9% | $23.6m | 1,744,492 | 5% | added |
| 38 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.8% | $21.2m | 68,000 | 127% | added |
| 39 | JNJ JOHNSON & JOHNSON | Healthcare | 0.8% | $20.3m | 132,786 | 21% | added |
| 40 | BIIB BIOGEN INC | Healthcare | 0.7% | $19.1m | 151,890 | 26% | added |
| 41 | CMPX COMPASS THERAPEUTICS INC | 0.7% | $18.6m | 7,149,493 | – | new | |
| 42 | ERAS ERASCA INC | Healthcare | 0.7% | $18.4m | 14,502,004 | 18% | added |
| 43 | MRK MERCK & CO INC | Healthcare | 0.7% | $17.4m | 219,178 | 52% | added |
| 44 | GS GOLDMAN SACHS GROUP INC | Financial Services | 0.6% | $17.1m | 24,108 | -6% | reduced |
| 45 | PALVELLA THERAPEUTICS INC NE | 0.6% | $16.1m | 714,463 | 0% | held | |
| 46 | PINS PINTEREST INC | Communication Services | 0.6% | $15.4m | 430,025 | – | new |
| 47 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.6% | $15.2m | 2,676,000 | -27% | reduced |
| 48 | GLUE MONTE ROSA THERAPEUTICS INC | 0.6% | $15.2m | 3,360,000 | 115% | added | |
| 49 | MRNA MODERNA INC | Healthcare | 0.5% | $14.3m | 517,163 | 0% | held |
| 50 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.5% | $12.0m | 275,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.